down arrow

Fredun Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
654.95
9.85 (1.53%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.59 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

646.30669.00

52 Week

635.001,024.00
Valuation
Technical
Day's Volume

CASH

3.59 k (82.98%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

1.59%

Held by 0 DIIs

Promoter

48.93%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Bearish range

  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated -2.55% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 309 Cr (Micro Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.11%

stock-summary
Debt Equity

0.86

stock-summary
Return on Equity

15.67%

stock-summary
Price to Book

2.54

Revenue and Profits (1 Year):
Net Sales:
102 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.11%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-18.13%
0%
-18.13%
1 Year
-19.33%
0.08%
-19.25%
2 Years
-32.5%
0.14%
-32.36%
3 Years
-30.81%
0.16%
-30.65%
4 Years
42.38%
0.47%
42.85%
5 Years
357.85%
1.31%
359.16%

Latest dividend: 0.7 per share ex-dividend date: Sep-23-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
27.60%
EBIT Growth (5y)
35.06%
EBIT to Interest (avg)
2.50
Debt to EBITDA (avg)
3.12
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.94
Tax Ratio
27.89%
Dividend Payout Ratio
2.11%
Pledged Shares
0
Institutional Holding
1.59%
ROCE (avg)
15.71%
ROE (avg)
9.91%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
33
Price to Book Value
2.54
EV to EBIT
9.13
EV to EBITDA
8.35
EV to Capital Employed
1.83
EV to Sales
1.00
PEG Ratio
0.61
Dividend Yield
0.11%
ROCE (Latest)
15.01%
ROE (Latest)
15.67%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Daulat Nariman Medhora (29.88%)

Highest Public shareholder

Nikhil Kishorchandra Vora (6.38%)

Individual Investors Holdings

44.55%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 17.53% vs 11.59% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 26.30% vs 21.97% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "101.84",
          "val2": "86.65",
          "chgp": "17.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13.23",
          "val2": "10.51",
          "chgp": "25.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.00",
          "val2": "3.77",
          "chgp": "32.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.33",
          "val2": "4.22",
          "chgp": "26.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.99%",
          "val2": "12.13%",
          "chgp": "0.86%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 29.23% vs 22.01% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 32.49% vs 54.63% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "184.43",
          "val2": "142.71",
          "chgp": "29.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.44",
          "val2": "17.21",
          "chgp": "42.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.22",
          "val2": "5.51",
          "chgp": "67.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.40",
          "val2": "6.34",
          "chgp": "32.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.25%",
          "val2": "12.06%",
          "chgp": "1.19%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 24.81% vs 17.85% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 30.02% vs 39.68% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "286.27",
          "val2": "229.36",
          "chgp": "24.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "37.67",
          "val2": "27.72",
          "chgp": "35.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.22",
          "val2": "9.28",
          "chgp": "53.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "13.73",
          "val2": "10.56",
          "chgp": "30.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.04%",
          "val2": "12.00%",
          "chgp": "1.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 26.33% vs 23.72% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 44.50% vs 70.50% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "346.58",
          "val2": "274.34",
          "chgp": "26.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "38.90",
          "val2": "29.60",
          "chgp": "31.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.65",
          "val2": "9.28",
          "chgp": "47.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "15.62",
          "val2": "10.81",
          "chgp": "44.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.22%",
          "val2": "10.79%",
          "chgp": "0.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
101.84
86.65
17.53%
Operating Profit (PBDIT) excl Other Income
13.23
10.51
25.88%
Interest
5.00
3.77
32.63%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.33
4.22
26.30%
Operating Profit Margin (Excl OI)
12.99%
12.13%
0.86%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 17.53% vs 11.59% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 26.30% vs 21.97% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
184.43
142.71
29.23%
Operating Profit (PBDIT) excl Other Income
24.44
17.21
42.01%
Interest
9.22
5.51
67.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.40
6.34
32.49%
Operating Profit Margin (Excl OI)
13.25%
12.06%
1.19%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 29.23% vs 22.01% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 32.49% vs 54.63% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
286.27
229.36
24.81%
Operating Profit (PBDIT) excl Other Income
37.67
27.72
35.89%
Interest
14.22
9.28
53.23%
Exceptional Items
0.00
0.00
Standalone Net Profit
13.73
10.56
30.02%
Operating Profit Margin (Excl OI)
13.04%
12.00%
1.04%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 24.81% vs 17.85% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 30.02% vs 39.68% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
346.58
274.34
26.33%
Operating Profit (PBDIT) excl Other Income
38.90
29.60
31.42%
Interest
13.65
9.28
47.09%
Exceptional Items
0.00
0.00
Standalone Net Profit
15.62
10.81
44.50%
Operating Profit Margin (Excl OI)
11.22%
10.79%
0.43%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 26.33% vs 23.72% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 44.50% vs 70.50% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Fredun Pharmaceuticals Ltd stock-summary
stock-summary
Fredun Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL.
Company Coordinates stock-summary
Company Details
26 Manoj Industrial Premises, G D Ambedkar Marg Wadala Mumbai Maharashtra : 400031
stock-summary
Tel: 91-22-40318111
stock-summary
http://www.fredungroup.com
stock-summary
business@fredungroup.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."